PL3368007T3 - Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego - Google Patents

Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego

Info

Publication number
PL3368007T3
PL3368007T3 PL16787869T PL16787869T PL3368007T3 PL 3368007 T3 PL3368007 T3 PL 3368007T3 PL 16787869 T PL16787869 T PL 16787869T PL 16787869 T PL16787869 T PL 16787869T PL 3368007 T3 PL3368007 T3 PL 3368007T3
Authority
PL
Poland
Prior art keywords
therapeutic use
sterile aqueous
ophthalmic solution
aqueous ophthalmic
solution
Prior art date
Application number
PL16787869T
Other languages
English (en)
Inventor
Martin Prinz
Original Assignee
Croma-Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croma-Pharma Gmbh filed Critical Croma-Pharma Gmbh
Publication of PL3368007T3 publication Critical patent/PL3368007T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL16787869T 2015-10-30 2016-10-27 Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego PL3368007T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15192362 2015-10-30
EP16787869.3A EP3368007B1 (en) 2015-10-30 2016-10-27 Therapeutic use of a sterile aqueous ophthalmic solution
PCT/EP2016/075939 WO2017072236A1 (en) 2015-10-30 2016-10-27 Therapeutic use of a sterile aqueous ophthalmic solution

Publications (1)

Publication Number Publication Date
PL3368007T3 true PL3368007T3 (pl) 2020-11-02

Family

ID=54476731

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16787869T PL3368007T3 (pl) 2015-10-30 2016-10-27 Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego

Country Status (15)

Country Link
US (1) US10583152B2 (pl)
EP (1) EP3368007B1 (pl)
JP (1) JP6817300B2 (pl)
KR (1) KR20180066104A (pl)
CN (1) CN108348455B (pl)
AR (1) AR106494A1 (pl)
BR (1) BR112018007686A2 (pl)
CA (1) CA3001634C (pl)
ES (1) ES2796361T3 (pl)
IL (1) IL258785B (pl)
MX (1) MX380088B (pl)
PL (1) PL3368007T3 (pl)
PT (1) PT3368007T (pl)
RU (1) RU2741912C2 (pl)
WO (1) WO2017072236A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
CN113318075B (zh) * 2021-06-24 2022-09-13 四川普锐特药业有限公司 一种乙酰半胱氨酸溶液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258781B (it) 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
FR2692582B1 (fr) 1992-06-18 1998-09-18 Flamel Tech Sa Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux.
AT406054B (de) 1998-11-04 2000-02-25 Andreas Bernkop-Schnuerch Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
GB2386900B (en) 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
CN101622017B (zh) * 2006-12-22 2018-09-11 克罗马制药有限责任公司 聚合物的用途
EP2425816A3 (en) 2007-01-31 2014-04-30 Allergan, Inc. A pharmaceutical composition for use in treating an ocular disease or condition and a method for producing the composition
US9452592B2 (en) 2007-08-28 2016-09-27 Cryovac, Inc. Multilayer film having an active oxygen barrier layer with radiation enhanced active barrier properties
CA2698189C (en) 2007-08-31 2016-07-19 Benjamin J. Sun Three-dimensional printing methods and materials for making dental products
US20090269417A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Thiolated chitosan gel
CA2721938C (en) 2008-04-24 2016-08-09 Medtronic, Inc. Chitosan-containing protective composition
CA2721937C (en) 2008-04-24 2016-07-12 Medtronic, Inc. Protective gel based on chitosan and oxidized polysaccharide
EP2389939A1 (en) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US9439925B2 (en) * 2010-04-06 2016-09-13 Synedgen, Inc. Methods and compositions for treating wounds utilizing chitosan compounds
ITMI20120847A1 (it) * 2012-05-16 2013-11-17 Labomar S R L Formulazione per sostanze a bassa biodisponibilità.
RS59383B1 (sr) 2014-05-07 2019-11-29 Croma Pharma Ges M B H Vodeni oftalmološki rastvor i postupak za lečenje sindroma suvog oka

Also Published As

Publication number Publication date
BR112018007686A2 (pt) 2018-11-06
IL258785A (en) 2018-06-28
RU2018119126A3 (pl) 2020-02-14
KR20180066104A (ko) 2018-06-18
IL258785B (en) 2022-08-01
CA3001634C (en) 2023-05-23
CA3001634A1 (en) 2017-05-04
MX2018004779A (es) 2018-06-19
RU2018119126A (ru) 2019-12-03
CN108348455B (zh) 2021-04-09
JP6817300B2 (ja) 2021-01-20
MX380088B (es) 2025-03-11
WO2017072236A1 (en) 2017-05-04
RU2741912C2 (ru) 2021-01-29
JP2018535962A (ja) 2018-12-06
US20180303865A1 (en) 2018-10-25
ES2796361T3 (es) 2020-11-26
EP3368007B1 (en) 2020-03-18
US10583152B2 (en) 2020-03-10
EP3368007A1 (en) 2018-09-05
PT3368007T (pt) 2020-06-17
AR106494A1 (es) 2018-01-17
CN108348455A (zh) 2018-07-31

Similar Documents

Publication Publication Date Title
IL252648B (en) Systems for providing non-invasive nerve rehabilitation to the patient
LT3122878T (lt) Terapija mrnr, skirta akių ligų gydymui
PT3212233T (pt) Terapia combinada para o tratamento de doenças
SG11201705138QA (en) Aqueous ophthalmic solution
IL250990A0 (en) Materials for human care
EP3212170A4 (en) Implantable medical devices for extended release of therapeutic agents
PT3273955T (pt) Tratamento de doenças respiratórias
SMT202000557T1 (it) Derivati di benzoassazinone per il trattamento di malattie della pelle
SG11201608257RA (en) A device for a medical treatment of a sclera
SI3210973T1 (sl) Heteroarilne spojine za zdravljenje oftalmičnih bolezni
PL3151814T3 (pl) Leczenie zmiany skórnej
IL247969B (en) A medicinal component for use in the treatment of infections
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
PL3047824T3 (pl) Urządzenie do laserowej terapii ludzkiego oka
IL258785A (en) Sterile aqueous solution for ophthalmic use
IL259381B (en) Mirabegron for the treatment of retinal diseases
PL3689341T3 (pl) Gabapentyna okulistyczna do leczenia deepitelializacji rogówki
IL259049A (en) Therapeutic use of a sterile aqueous ophthalmic solution
IL275150A (en) System for hypothermia treatment of a patient
HK1260500A1 (en) Therapeutic use of a sterile aqueous ophthalmic solution
EP3212202A4 (en) Use of therapeutic agents
GB201501800D0 (en) Treatment of medical conditions
AU2014904330A0 (en) Use of therapeutic agents
SG11201700331RA (en) Prophylactic or therapeutic agent for a posterior ocular disease
GB201306413D0 (en) The local treatment of ophthalmic diseases